Clarification of Definitions of Hyperprogressive Disease During Immunotherapy for NSCLC
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
JAMA Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Clarification of Definitions of Hyperprogressive Disease During Immunotherapy for Non-Small Cell Lung Cancer
JAMA Oncol 2020 Jun 11;[EPub Ahead of Print], B Kas, H Talbot, R Ferrara, C Richard, JP Lamarque, S Pitre-Champagnat, D Planchard, C Balleyguier, B Besse, L Mezquita, N Lassau, C CaramellaFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.